CAH - Cardinal Health - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082
Pharmaceuticals, Medical Supplies, Surgical Products, Gloves, Needles, Syringes
Cardinal Health Inc. is a leading healthcare services and products company that operates globally, with a presence in the United States, Canada, Europe, Asia, and other international markets. The company provides tailored solutions to a wide range of healthcare providers, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients receiving care in their homes.
Cardinal Health's business is divided into two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company distributes a vast array of products, including branded and generic pharmaceuticals, specialty pharmaceuticals, over-the-counter healthcare products, and medical supplies. Additionally, it offers specialized services to pharmaceutical manufacturers and healthcare providers, such as pharmacy management services to hospitals and repackaging of generic pharmaceuticals and over-the-counter healthcare products.
In the medical products space, Cardinal Health designs, manufactures, sources, and distributes a broad portfolio of Cardinal Health branded products, including exam and surgical gloves, needles, syringe, and sharps disposals, compression solutions, incontinence products, nutritional delivery systems, wound care products, and more. The company also distributes a range of national brand products, including medical, surgical, and laboratory products, and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers.
Furthermore, Cardinal Health assembles and sells sterile and non-sterile procedure kits, and manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments. The company also leverages its integrated technology solutions to optimize direct shipments and streamline logistics for its customers.
Founded in 1979, Cardinal Health is headquartered in Dublin, Ohio, and has established itself as a trusted partner to healthcare providers around the world. With a strong commitment to improving patient care and outcomes, the company continues to innovate and expand its offerings to meet the evolving needs of the healthcare industry.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
CAH Stock Overview
Market Cap in USD | 26,957m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC SubIndustry | Health Care Distributors |
TER | 0.00% |
IPO / Inception | 1987-12-31 |
CAH Stock Ratings
Growth 5y | 86.5 |
Fundamental | 43.5 |
Dividend | 52.0 |
Rel. Performance vs Sector | -0.34 |
Analysts | 3.44/5 |
Fair Price Momentum | 123.17 USD |
Fair Price DCF | 335.19 USD |
CAH Dividends
Dividend Yield 12m | 1.80% |
Yield on Cost 5y | 5.14% |
Dividends CAGR 5y | 0.80% |
Payout Consistency | 95.5% |
CAH Growth Ratios
Growth 12m | 26.93% |
Growth Correlation 12m | 27% |
Growth Correlation 3m | 84% |
CAGR 5y | 23.33% |
CAGR/Mean DD 5y | 2.86 |
Sharpe Ratio 12m | 1.04 |
Alpha vs SP500 12m | -2.80 |
Beta vs SP500 5y weekly | 0.82 |
ValueRay RSI | 56.74 |
Volatility GJR Garch 1y | 19.51% |
Price / SMA 50 | 3.91% |
Price / SMA 200 | 7.97% |
Current Volume | 1490.7k |
Average Volume 20d | 1992.1k |
External Links for CAH Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 05, 2024, the stock is trading at USD 111.98 with a total of 1,490,687 shares traded.
Over the past week, the price has changed by +2.46%, over one month by -1.24%, over three months by +17.32% and over the past year by +25.81%.
According to ValueRays Forecast Model, CAH Cardinal Health will be worth about 134.5 in October 2025. The stock is currently trading at 111.98. This means that the stock has a potential upside of +20.15%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 117.4 | 4.85 |
Analysts Target Price | 98.6 | -12.0 |
ValueRay Target Price | 134.5 | 20.1 |